Advertisement RxElite and Premier sign multi-source contract - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

RxElite and Premier sign multi-source contract

RxElite, a manufacturer and marketer of specialty generic prescription drug products, has signed a multi-source contract award with Premier for the sale of the company's anesthetic gas products, Sevoflurane and Isoflurane.

RxElite was awarded this multi-source contract listing for all classes of trade and the company’s anesthetic gas products are immediately available to all Premier members. Sevoflurane is the commonly used anesthetic gas in the US and Isoflurane continues to be widely used in anesthesia practice.

Jonathan Houssian, CEO of RxElite, said: “This contract has delivered significant value to the Premier members that have already implemented it and we look forward to continuing to drive value for all Premier members.”